Wilkinson, Lua
Novo Nordisk (United States)
2 papers on CoChatORCID 0000-0001-6665-9463
Most cited papers
- Verified
Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study
Wilkinson, L., Yi, N., Mehta, T., Judd, S., & Garvey, W. T. (2020) · PLOS Medicine
Diabetes, Cardiovascular Risks, and LipoproteinsStatistical Methods in Epidemiology
Cited by 47
- Verified
Effect of semaglutide 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults with overweight or obesity
Wilkinson, L., Holst‐Hansen, T., Laursen, P. N., Rinnov, A. R., Batterham, R. L., & Garvey, W. T. (2023) · Obesity
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free